title: Effect of dietary laminarin and fucoidan on selected microbiota, intestinal morphology and immune status of the newly weaned pig.
abstract: A 2 × 2 factorial experiment was conducted to investigate the interactions between laminarin (LAM; 0 and 300 parts per million (ppm)) and fucoidan (FUC; 0 and 240 ppm) levels on intestinal morphology, selected microbiota and inflammatory cytokine gene expression in the weaned pig. There was an interaction between LAM and FUC supplementation on the Enterobacteriaceae population (P< 0·05) and the abundance of attaching and effacing Escherichia coli (AEEC) strains (P< 0·05) in the colon. Pigs offered the FUC diet had a reduced Enterobacteriaceae population compared with pigs offered the basal diet. However, the effect of FUC on the Enterobacteriaceae population was not observed when combined with LAM. Pigs offered the LAM diet had reduced abundance of AEEC strains compared with pigs offered the basal diet. However, there was no effect of LAM on the abundance of AEEC strains when combined with FUC. There was an interaction between LAM and FUC supplementation on villous height (P< 0·01) and the villous height:crypt depth ratio (P< 0·01) in the duodenum. Pigs offered the LAM or FUC diet had an increased villous height and villous height:crypt depth ratio compared with pigs offered the basal diet. However, there was no effect of the LAM and FUC combination diet on intestinal morphology. Pigs offered the LAM-supplemented diets had a lower IL-6 (P< 0·05), IL-17A (P< 0·01) and IL-1β (P< 0·01) mRNA expression in the colon compared with pigs offered the diets without LAM. In conclusion, supplementation with either LAM or FUC alone modified intestinal morphology and selected intestinal microbiota, but these effects were lost when offered in combination.
authors.affiliation: School of Agriculture and Food Science, University College Dublin, Lyons Research Farm, Newcastle, County Dublin, Republic of Ireland.
authors.forename: A M
authors.initials: AM
authors.lastname: Walsh
authors.forename: T
authors.initials: T
authors.lastname: Sweeney
authors.forename: C J
authors.initials: CJ
authors.lastname: O'Shea
authors.forename: D N
authors.initials: DN
authors.lastname: Doyle
authors.forename: J V
authors.initials: JV
authors.lastname: O'Doherty
mesh_terms: D000818:Animals; D003106:Colon / Q000187:drug effects / Q000276:immunology / Q000378:metabolism / Q000382:microbiology; D019587:Dietary Supplements; D004359:Drug Therapy, Combination; D004386:Duodenum / Q000033:anatomy & histology / Q000187:drug effects; D004755:Enterobacteriaceae / Q000187:drug effects*; D004926:Escherichia coli / Q000187:drug effects; D005936:Glucans; D053583:Interleukin-1beta / Q000235:genetics / Q000378:metabolism; D015850:Interleukin-6 / Q000235:genetics / Q000378:metabolism; D007413:Intestinal Mucosa / Q000033:anatomy & histology / Q000187:drug effects* / Q000276:immunology / Q000382:microbiology; D007422:Intestines / Q000033:anatomy & histology / Q000187:drug effects* / Q000276:immunology / Q000382:microbiology; D064307:Microbiota / Q000187:drug effects; D000459:Phaeophyceae / Q000737:chemistry*; D011134:Polysaccharides / Q000494:pharmacology*; D012333:RNA, Messenger / Q000378:metabolism; D013552:Swine; D014886:Weaning
chemical_list: D005936:Glucans; D053583:Interleukin-1beta; D015850:Interleukin-6; D011134:Polysaccharides; D012333:RNA, Messenger; C008247:laminaran; C007789:fucoidan